Clinical Trials Logo
  1. Home
  2. Coronary Artery Disease
  3. NCT02228343
  4. Details
NCT02228343 Clinical Trial

A Prospective Trial of Ayurveda for Coronary Artery Disease

Coronary Artery Disease Clinical Trial

Official title:
A Prospective Trial of Ayurveda for Coronary Artery Disease

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02228343
Other study ID # UNM2013.1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2013
Est. completion date January 2014

Study information
Verified date October 2023
Source University of New Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Can Ayurvedic therapy improve markers of cardiovascular health and cardiovascular risk factors in patients with coronary artery disease.

Description:

Patients with established coronary artery disease will be treated with 90 days of Ayurvedic therapy to include yoga, meditation, breathing exercises,and herbs. Arterial stiffness, weight, BMI, BP, medications, cholesterol, LDL, HDL, triglyceride, HS-CRP will be measured at baseline and after 90 days of therapy.

Recruitment information / eligibility
Status Completed
Enrollment 19
Est. completion date January 2014
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - stable coronary artery disease (prior mi, coronary angioplasty or stent, coronary bypass surgery) Exclusion Criteria: - age < 18 years - life expectancy < 6 months - pregnancy or breast feeding - unwilling or unable to complete 90 days of therapy - already receiving/taking Ayurvedic therapy - unable to converse in or understand English language

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Ayurveda
Ayurveda includes meditation, yoga, breathing exercises, herbs

Locations
Country Name City State
United States University of New Mexico Medical Group McMahon Cardiology Albuquerque New Mexico

Sponsors (1)
Lead Sponsor Collaborator
University of New Mexico

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Arterial stiffness, measured as pulse wave velocity meters/second 3 months
Secondary Body mass index (BMI) 3 months
Secondary Blood pressure in mm Hg 3 months
Secondary Total cholesterol in mg/dl 3 months
Secondary LDL cholesterol in mg/dl 3 months
Secondary HDL cholesterol in mg/dl 3 months
Secondary Triglyceride in mg/dl 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A